Cargando…

Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism

[Image: see text] Caffeine, the most consumed psychoactive substance worldwide, may have beneficial effects on Parkinson’s disease (PD) therapy. The mechanism by which caffeine contributes to its antiparkinsonian effects by acting as either an adenosine A(2A) receptor (A(2A)R) neutral antagonist or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Dueñas, Víctor, Gómez-Soler, Maricel, López-Cano, Marc, Taura, Jaume J., Ledent, Catherine, Watanabe, Masahiko, Jacobson, Kenneth A., Vilardaga, Jean-Pierre, Ciruela, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245165/ https://www.ncbi.nlm.nih.gov/pubmed/25268872 http://dx.doi.org/10.1021/cb5005383

Ejemplares similares

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2015)

Revealing Adenosine A(2A)-Dopamine D(2) Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2019)

PBF509, an Adenosine A(2A) Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders
por: Núñez, Fabiana, et al.
Publicado: (2018)

Photomodulation of G Protein-Coupled Adenosine Receptors by a Novel Light-Switchable Ligand
por: Bahamonde, María Isabel, et al.
Publicado: (2014)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

The Parkinson’s disease-associated GPR37 receptor interacts with striatal adenosine A(2A) receptor controlling its cell surface expression and function in vivo
por: Morató, Xavier, et al.
Publicado: (2017)

Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)

Inverse agonism and its therapeutic significance
por: Khilnani, Gurudas, et al.
Publicado: (2011)

Optical Control of Adenosine-Mediated Pain Modulation
por: Hüll, Katharina, et al.
Publicado: (2021)

The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease
por: Romero-Fernandez, Wilber, et al.
Publicado: (2022)

Optical Control of Adenosine A(3) Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?
por: Ciruela, Francisco, et al.
Publicado: (2022)

Molecular Vibration-Activity Relationship in the Agonism of Adenosine Receptors
por: Chee, Hyun Keun, et al.
Publicado: (2013)

Decreased striatal adenosine A(2A)-dopamine D(2) receptor heteromerization in schizophrenia
por: Valle-León, Marta, et al.
Publicado: (2020)

Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides
por: Nicke, Lennart, et al.
Publicado: (2019)

Adenosine A(1)-A(2A) Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
por: Berg, Kelly A, et al.
Publicado: (2018)

A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes
por: Michel, Martin C., et al.
Publicado: (2020)

A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Brust, Richard, et al.
Publicado: (2018)

Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
por: Ali, Ramadan A., et al.
Publicado: (2019)

Adenosine A(1)-A(2A) Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects
por: Lanznaster, Débora, et al.
Publicado: (2019)

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Portraying G Protein-Coupled Receptors with Fluorescent Ligands
por: Ciruela, Francisco, et al.
Publicado: (2014)

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A(2A) and dopamine D(2) receptors
por: Guixà-González, Ramon, et al.
Publicado: (2016)

Adenosine A(2A) Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients
por: Godoy-Marín, Héctor, et al.
Publicado: (2021)

Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor
por: Chakraborty, Raja, et al.
Publicado: (2014)

Structural basis for receptor selectivity and inverse agonism in S1P(5) receptors
por: Lyapina, Elizaveta, et al.
Publicado: (2022)

Special Issue: Adenosine Receptors
por: Ciruela, Francisco, et al.
Publicado: (2017)

Clues from a missense mutation of the adenosine A(1) receptor gene associated with early-onset Parkinson’s disease
por: Ferré, Sergi, et al.
Publicado: (2023)

Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
por: Lassen, Martin Lyngby, et al.
Publicado: (2022)

In vivo assessment of coronary flow and cardiac function after bolus adenosine injection in adenosine receptor knockout mice
por: Teng, Bunyen, et al.
Publicado: (2016)

The brain strikes back: Hypothalamic targets for peripheral CB(1) receptor inverse agonism
por: Cota, Daniela
Publicado: (2017)

Inverse agonism of retinoic acid receptors directs epiblast cells into the paraxial mesoderm lineage
por: Russell, Ryan P., et al.
Publicado: (2018)

Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A(3) Receptor Subtype
por: Coppi, Elisabetta, et al.
Publicado: (2021)

Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
por: Jacobson, Kenneth A., et al.
Publicado: (2020)

Biased agonism
por: Kenakin, Terry
Publicado: (2009)

Agonizing Hedgehog
por: Weitzman, Jonathan B
Publicado: (2002)

Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives
por: Reichert, Carolin Franziska, et al.
Publicado: (2022)

Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand
por: Marcotte, Douglas J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ihuo24ond70pf31db7bpeid8cj